1 completed, 1 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 3 | 1 | Terminated 1 |
Follow eleclazine: new trials by email Literature Review of eleclazine trials Research Report on eleclazine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease GS-6615, Placebo - Ischemic Heart Disease | Phase 2 | Withdrawn | Gilead Sciences | 2015-05-01 | 2015-06-08 | |
| Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy Eleclazine, Placebo - Hypertrophic Cardiomyopathy | Phase 2 / Phase 3 | Terminated | Gilead Sciences | 172 | 2015-02-05 | 2018-09-24 |
| Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator Eleclazine, Placebo to match eleclazine - Ventricular Arrhythmia | Phase 2 | Completed | Gilead Sciences | 313 | 2014-09-01 | 2019-04-09 |
Angina Pectoris (2) · Angina, Stable (1) · Cardiomyopathies (1) · Cardiomyopathy, Hypertrophic (1) · Cardiomyopathy, Hypertrophic, Familial (1) · Coronary Artery Disease (1) · Coronary Disease (1) · Dyspnea (1) · Heart Failure (1) · Hypertrophy (1) · Myocardial Ischemia (1) · Shock (1) · Tachycardia, Ventricular (1) · Ventricular Fibrillation (1)
Gilead Sciences (3)
Germany (2) · Israel (2) · Netherlands (2) · United States (2) · Australia (1) · Canada (1) · Czechia (1) · Denmark (1) · France (1) · Hungary (1) · Italy (1) · Poland (1) · United Kingdom (1)
Patrick Yue, MD (1)
2014 (1)